What Is BPC-157?

BPC-157 is a short, lab-made peptide of fifteen amino acids, based on a piece of a protein found in human stomach fluid. A peptide is a short chain of amino acids, and amino acids are the small molecules living things build with. It has been studied mostly in rats and mice. In those animals it has been reported to speed up healing in a surprising range of tissues. It has not been tested in proper human trials.

That last sentence is the one that usually goes missing. This compound gets written about with a great deal of confidence, in both directions at once. One page will tell you it heals almost anything. The next will tell you it is nonsense. Neither of those is what the evidence actually supports.

So this article does not hand you a verdict to carry around. It tries instead to leave you able to judge the next thing you read about this compound. That turns out to be the more useful thing to own.

What does the name BPC-157 actually mean?

BPC stands for body protection compound. That is the name researchers gave to a protein they identified in human gastric juice — the fluid your stomach produces to break food down. The 157 identifies one particular fragment of that protein: a stretch of fifteen amino acids lifted out of the longer chain and then built from scratch in a laboratory.

So the name is doing two jobs at once, and only one of them is a fact. The 157 is a plain label, like a file number. "Body protection compound" is a description of what the people who named it thought it was for.

That distinction is worth taking away from this page, because it reaches far beyond one peptide. Researchers name things early, when they have an observation and an expectation. The name records the expectation. It is a little like a street called Orchard Way. Somebody had apple trees in mind. The name tells you nothing about whether any are standing there now.

None of that makes the name dishonest. It described a protein that appeared to protect stomach tissue, which is a reasonable thing to call it. But it is a hypothesis wearing a name tag, and it reads like a proven claim.

What do researchers think it might do?

The leading idea is about blood supply. The claim made most often for BPC-157 in the research literature is that it encourages small new blood vessels to grow at the site of an injury 14. Scientists call that angiogenesis, from older words meaning vessel and beginning. In plain terms: new plumbing, grown where damage has happened.

It is worth being concrete about why that would matter, because it is not obvious. Healing is construction work. A damaged area needs raw materials delivered, waste hauled away, and repair cells brought in from elsewhere. All of it arrives through the blood. A building site with no delivery road does not stop entirely, but it slows down to whatever the crew can carry in by hand.

Some tissues are exactly that badly served. A tendon is the tough cord that connects a muscle to a bone — the one at the back of your heel, joining your calf muscle to your heel bone, is the largest one you have. Tendons are famously slow to heal, and part of the reason is that they have a poor blood supply to begin with. The same goes for ligaments, the cords that tie one bone to another.

So the proposal is not that this compound repairs tissue itself. It is that it improves the delivery road, and lets the tissue's own repair crew work at the speed it otherwise could. If that were right, it would also explain something that at first looks suspicious — reports of benefit in a lot of unrelated places at once. Something acting on blood supply would show up wherever blood supply is the thing holding healing back 4.

Read all of that as a hypothesis, which is what it is. It fits the observations gathered so far. It has not been tested where it would count.

What does the research actually consist of?

Mostly rats and mice. That is the plain answer, and it may be the single most useful fact on this page.

There are several hundred published studies, and the great majority are animal experiments. In each one an injury was usually made deliberately, and healing was measured afterwards — in stomach lining, in tendon, in muscle, in bone 13.

Alongside that sits a smaller amount of work done outside any animal at all. Researchers can keep living cells alive in a shallow dish of nutrient liquid, inside a warm cabinet, and watch how they behave when something is added. That is what people mean by cells in a dish. In one experiment of roughly this kind, small pieces of living tendon were kept alive outside the body, and the compound was reported to make the repair cells grow out, survive and travel faster than they otherwise did 2.

What does not exist anywhere is a proper trial in people. The standard test is a randomized controlled trial: volunteers are assigned by chance to get either the real thing or a dummy version, and the people assessing them are kept in the dark about who got which. That design exists because it is very hard to fool. Nothing of the kind has been published for this compound.

Now the balancing half, and please do not skip it. Animal research is not a fake or lesser version of human research. It is an earlier stage of the same process, and almost every medicine you have taken passed through it. Testing in animals before people is an ethical requirement, not a shortcut around one. A finding in rats is a legitimate reason to go and run the human study. It is not a substitute for having run one.

There is a companion explainer on this site devoted entirely to that gap — why laboratory animals are bred, housed and injured in ways that make an effect easy to see, and why so many findings that look solid in mice do not survive the trip. If you read one other thing after this page, make it that one.

What is genuinely not known

Here is the list, without drama. These are ordinary gaps, and filling them is exactly what the long, expensive middle of drug development is for.

• Whether it does anything at all in a person. Every reported benefit comes from an animal or from cells in a dish. The step across to humans has not been attempted in any rigorous way.
• How much would be needed. Figures circulate online with impressive precision. They are extrapolations from rodent studies, copied from one page to the next, and they rest on no human measurement whatsoever.
• How long it stays in a human body. Nobody has published a study measuring how quickly a person absorbs it, where it goes, or how fast it is cleared out. Without that, there is no sound way to reason from an animal experiment to a human one.
• Whether it is safe over a long period. Animal healing studies are short, usually days or weeks. A problem that takes months or years to surface has no opportunity to surface in a study that ends first.
• How it behaves alongside anything else a person might be taking. Substances interact. Nobody has looked.

One of those deserves a paragraph on its own, and it needs stating carefully. The main proposed mechanism is the growth of new blood vessels. That is a genuinely helpful process in a tissue trying to repair itself. It is not a process you would want encouraged indiscriminately, everywhere in the body, over a long stretch of time — because some things grow better when they are better supplied with blood, and not all of them are things anyone would want to help along.

That is not a claim that this compound causes harm. No such thing has been shown, and it would be just as dishonest to imply it. It is a reason the long-term safety question is a serious one rather than a formality. It is also a reason that "no reported problems" carries much less weight than it sounds like it does, when hardly anybody has been watched for long enough to report anything.

Is it a medicine? Is it legal?

It is not a medicine, in the particular sense that word carries in law. A medicine is a substance a regulator has examined and then permitted to be sold for treating something. In the United States that regulator is the Food and Drug Administration; in Britain, the Medicines and Healthcare products Regulatory Agency; across the European Union, the European Medicines Agency. None of them has approved BPC-157 for anything, and none has an application in front of it, because the trials that would support one have never been run.

What it is sold as instead is a laboratory research chemical. Products in that category are labeled research use only, which is a legal classification rather than a quality claim. It means the seller is not offering the material for human use, and that nobody has checked it the way a pharmacy medicine gets checked.

It is also banned in competitive sport. The World Anti-Doping Agency lists it among prohibited substances, which means an athlete who tests positive faces the usual consequences regardless of what they intended.

The honest summary is the useful one

Interesting, and genuinely unproven in people. That is the whole of it, and it is a real position rather than a fence to sit on.

Interesting is earned. There is a large and internally consistent body of animal work, a proposed mechanism that would make sense of its unusual breadth, and some results from laboratories that had no hand in producing the original claims. Taken together, that is a reasonable case for wanting somebody to run a human trial.

Unproven is equally earned, and it is not a technicality. Nobody knows whether any of it carries across to a person. The list of compounds that healed things beautifully in rodents and then did nothing measurable in humans is long, and it is long without anybody having been dishonest.

So when you meet the next confident sentence about this peptide, you have somewhere to put it. If it says the compound was shown to heal something, ask what it was shown in. If it states a quantity, ask where that number came from, given that no human study has measured one. And if it says the whole thing is worthless, ask which evidence it failed — because it has not been put to the test that could fail it.

A reader holding "interesting, unproven" is in better shape than a reader who has been told it definitely works, and in better shape than one who has been told it is worthless. Both of those people are carrying something firmer than the evidence supports. Only one of the three positions is actually true at the moment, and it happens to be the uncomfortable one in the middle.